Mast_Group.svg
TAB/CIP0.2

ADATAB® Ciprofloxacin

MAST® ADATAB® is a lyophilised tablet designed for rapid preparation of antibiotic-supplemented agar plates for breakpoint or MIC susceptibility testing of clinical bacteria. Each tablet contains an exact antibiotic dose to produce the required breakpoint concentration in 100 ml of medium. Key benefits include: Reproducible, accurate, easy to interpret, control strains can be included on the same plate and no weighing or dilution required.

Enquire now

Product Variants

ADATAB® Ciprofloxacin
Product NameProduct CodePack SizeStatusMOQWeightStorage TemperatureDimensionsGTINCommodity CodeIFU DocumentsMSDS Documents
ADATAB® Ciprofloxacin 0.2mgTAB/CIP0.225 x 100ml TabletsStock164 g2 - 8 ˚C53 x 90 x 53 mm1506039237314638229000
ADATAB® Ciprofloxacin 0.8mgTAB/CIP0.825 x 100ml TabletsStock164 g2 - 8 ˚C53 x 90 x 53 mm1506039237315338229000

Related Products

  • MAST Group
    Ciprofloxacin 0.003ug
    CIP0.003/NCE
  • MAST Group
    ADATAB® Ciprofloxacin 0.8mg
    TAB/CIP0.8
  • Ciprofloxacin 5µg
    AST
    Ciprofloxacin 5µg
    CIP5C
    MASTDISCS® Antibiotic Susceptibility Test Discs are high-quality paper discs impregnated with specific antibiotics for the determination of susceptibility of common bacterial pathogens using disc diffusion testing methods. MASTDISCS® deliver reliable and consistent results in routine microbiology laboratories.
    More info
  • MAST Group
    Ciprofloxacin 0.003µg
    CIP0.003C/NCE